메뉴 건너뛰기




Volumn 26, Issue 10, 2013, Pages 571-580

Central amyloid-β-specific single chain variable fragment ameliorates Aβ aggregation and neurotoxicity

Author keywords

Alzheimer's disease; amyloid beta; immunotherapy; single chain antibody

Indexed keywords

ALZHEIMER'S DISEASE; AMYLOID BETAS; BUILDING BLOCKES; FUNCTIONALIZATIONS; IMMUNOTHERAPY; SINGLE CHAIN VARIABLE FRAGMENTS; SINGLE-CHAIN ANTIBODIES; THERAPEUTIC ANTIBODIES;

EID: 84885008285     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzt025     Document Type: Article
Times cited : (15)

References (58)
  • 46
    • 73349091534 scopus 로고    scopus 로고
    • Bapineuzumab 201 Clinical Trial I.
    • Salloway, S., Sperling, R., Gilman, S., et al.; Bapineuzumab 201 Clinical Trial, I. (2009) Neurology, 73, 2061-2070.
    • (2009) Neurology , vol.73 , pp. 2061-2070
    • Salloway, S.1    Sperling, R.2    Gilman, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.